Telix and radioisotope maker ITM merge in deal worth up to $2.35B
Telix Pharmaceuticals is buying German radioisotope manufacturer ITM Isotope Technologies Munich SE for $1.65 billion upfront, but some deal milestones hinge on a recently rejected drug. The merger will combine ITM’s commercial radioisotope manufacturing with ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.